Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management
2015
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
2015 Standout
Chimerism of the Transplanted Heart
2002 Standout
Cardiac Troponin T in Patients With Clinically Suspected Myocarditis
1997
Thrombolytic Therapy for Obstruction of Mechanical Prosthetic Valves
1996
Cardiac transplantation: Pre-transplant infectious diseases evaluation and post-transplant prophylaxis
2002
Contractility of the transplanted, denervated human heart
1991
Exercise Standards for Testing and Training
2013 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Noninvasive Imaging in Myocarditis
2006
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms
2001
Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia
1996 Standout
Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography
2000
Accelerated atherosclerosis in saphenous vein bypass grafts: A spectrum of diffuse plaque instability
2002
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies.
1993
Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: A novel cardiac syndrome mimicking acute myocardial infarction
2002 Standout
Cardiac complications of radiation therapy
2005
Clinical role of indium-111 antimyosin imaging
1991
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
2009 Standout
Nuclear imaging in cardiac amyloidosis
2009
Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study
2005
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis—evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis
1998
Myocarditis
2011 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
Indium-111 monoclonal antimyosin cardiac scintigraphy in suspected acute myocarditis: evolution and diagnostic impact
2003
Update on Myocarditis
2012 Standout
Myocarditis
2000 Standout
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995 Standout
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study
1999
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Human viral cardiomyopathy
2003
Myocarditis
2009 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis.
1990
Moderate drinking and reduced risk of heart disease.
1999
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Myocarditis
2006 Standout
Guidelines for clinical use of cardiac radionuclide imaging report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology
1995
Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies
2014
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis
2000
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Health Lifestyle Theory and the Convergence of Agency and Structure
2005 Standout
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
2013
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
1996 Standout
Meta-analysis of the association of enteroviruses with human heart disease
1997
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias.
1994
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States
2005 Standout
Task force 5: Complications
1993
Heart Transplantation–Associated Perioperative Ischemic Myocardial Injury
1996
Works of D Obrador being referenced
Dopamine treatment of locally procured donor hearts: relevance on postoperative cardiac histology and function
1989
Active myocardial damage without attending inflammatory response in dilated cardiomyopathy
1993
Spectrum of Alcohol-Induced Myocardial Damage Detected by Indium-111–Labeled Monoclonal Antimyosin Antibodies
1997
Active myocardial damage in hypertthyroidism
1995
Enterovirus persistence and myocardial damage detected by 111In-monoclonal antimyosin antibodies in patients with dilated cardiomyopathy
1996
High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy
1989
Reversal of rejection-induced coronary vasculitis detected early after heart transplantation with increased immunosuppression.
1989
Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by 111In monoclonal antimyosin antibodies.
1994
Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications.
1990
Epidemiologic evidence of transmission of donor-related bacterial infection through a transplanted heart.
1997
Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection.
1988
Coronary Arterial Spasm and Cardiac Arrest following Mediastinal Radiation Therapy for Hodgkin's Disease
1991
Successful thrombolytic therapy for prosthetic pulmonary valve thrombosis evaluated by Doppler echocardiography
1992